RA CAPITAL MANAGEMENT, L.P.

Q4 2024 13F Holdings

  • Location
    boston, MA
  • Num holdings

    89

  • Value ($000)

    $7,514,204

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001346824
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
ASND
ASND

ASCENDIS PHARMA A/S - ADR

SH
04351P101
$1.39B
19 %

10,112,744

PCVX
PCVX

VAXCYTE INC

SH
92243G108
$711.30M
10 %

8,689,190

JANX
JANX

JANUX THERAPEUTICS INC

SH
47103J105
$554.98M
7 %

10,365,652

RYTM
RYTM

RHYTHM PHARMACEUTICALS INC

SH
76243J105
$340.61M
5 %

6,084,412

LEGN
LEGN

LEGEND BIOTECH CORP-ADR

SH
52490G102
$244.28M
3 %

7,506,934

EWTX
EWTX

EDGEWISE THERAPEUTICS INC

SH
28036F105
$237.87M
3 %

8,909,091

---

NEWAMSTERDAM PHARMA CO NV

SH
N62509109
$227.32M
3 %

8,845,000

---

WAVE LIFE SCIENCES LTD

SH
Y95308105
$225.16M
3 %

18,202,009

ACLX
ACLX

ARCELLX INC

SH
03940C100
$213.76M
3 %

2,787,327

RNA
RNA

AVIDITY BIOSCIENCES INC

SH
05370A108
$183.22M
2 %

6,300,408

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 89